| Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease B Bellaver, G Povala, PCL Ferreira, JP Ferrari-Souza, DT Leffa, ... Nature medicine 29 (7), 1775-1781, 2023 | 159 | 2023 |
| Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography J Therriault, M Vermeiren, S Servaes, C Tissot, NJ Ashton, AL Benedet, ... JAMA neurology 80 (2), 188-199, 2023 | 136 | 2023 |
| Astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis B Bellaver, JP Ferrari-Souza, L Uglione da Ros, SF Carter, ... Neurology 96 (24), e2944-e2955, 2021 | 99 | 2021 |
| Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease JP Ferrari-Souza, PCL Ferreira, B Bellaver, C Tissot, YT Wang, DT Leffa, ... Molecular psychiatry 27 (11), 4781-4789, 2022 | 90 | 2022 |
| Comparing tau status determined via plasma pTau181, pTau231 and [18F] MK6240 tau-PET C Tissot, J Therriault, P Kunach, AL Benedet, TA Pascoal, NJ Ashton, ... EBioMedicine 76, 2022 | 47 | 2022 |
| APOEε4 associates with microglial activation independently of Aβ plaques and tau tangles JP Ferrari-Souza, FZ Lussier, DT Leffa, J Therriault, C Tissot, B Bellaver, ... Science Advances 9 (14), eade1474, 2023 | 45 | 2023 |
| The GABAergic system in Alzheimer’s disease: a systematic review with meta-analysis G Carello-Collar, B Bellaver, PCL Ferreira, JP Ferrari-Souza, VG Ramos, ... Molecular Psychiatry 28 (12), 5025-5036, 2023 | 31 | 2023 |
| Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologies MA De Bastiani, B Bellaver, WS Brum, DG Souza, PCL Ferreira, ... Brain, behavior, and immunity 110, 175-184, 2023 | 30 | 2023 |
| Blood‐brain barrier integrity impacts the use of plasma amyloid‐β as a proxy of brain amyloid‐β pathology B Bellaver, A Puig‐Pijoan, JP Ferrari‐Souza, DT Leffa, FZ Lussier, ... Alzheimer's & Dementia 19 (9), 3815-3825, 2023 | 20 | 2023 |
| Neuropsychiatric symptoms and microglial activation in patients with Alzheimer disease CS Aguzzoli, PCL Ferreira, G Povala, JP Ferrari-Souza, B Bellaver, ... JAMA Network Open 6 (11), e2345175-e2345175, 2023 | 17 | 2023 |
| Plasma p‐tau231 and p‐tau217 inform on tau tangles aggregation in cognitively impaired individuals PCL Ferreira, J Therriault, C Tissot, JP Ferrari‐Souza, AL Benedet, ... Alzheimer's & Dementia 19 (10), 4463-4474, 2023 | 17 | 2023 |
| Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer’s disease pathophysiology in cognitively unimpaired older adults DT Leffa, JP Ferrari-Souza, B Bellaver, C Tissot, PCL Ferreira, WS Brum, ... Molecular Psychiatry 28 (3), 1248-1255, 2023 | 16 | 2023 |
| Uglione da Ros L, Carter SF, Rodriguez-Vieitez E, Nordberg A, Pellerin L, Rosa-Neto P, Leffa DT, Zimmer ER. Astrocyte biomarkers in Alzheimer disease: a systematic review and … B Bellaver, JP Ferrari-Souza Neurology 96 (24), e2944-55, 2021 | 16 | 2021 |
| APOEε4 potentiates amyloid β effects on longitudinal tau pathology JP Ferrari-Souza, B Bellaver, PCL Ferreira, AL Benedet, G Povala, ... Nature aging 3 (10), 1210-1218, 2023 | 13 | 2023 |
| The glutamatergic system in alzheimer’s disease: A systematic review with meta-analysis C Soares, LU Da Ros, LS Machado, A Rocha, G Lazzarotto, ... Molecular Psychiatry, 1-13, 2024 | 11 | 2024 |
| The association of age-related and off-target retention with longitudinal quantification of [18F] MK6240 tau PET in target regions C Tissot, S Servaes, FZ Lussier, JP Ferrari-Souza, J Therriault, ... Journal of Nuclear Medicine 64 (3), 452-459, 2023 | 11 | 2023 |
| A three‐range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease WS Brum, MA De Bastiani, A Bieger, J Therriault, JP Ferrari‐Souza, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 8 (1 …, 2022 | 10 | 2022 |
| Endometriose EE Moretto, JPF Souza, LP Farenzena, LG Crippa, MT Pedrotti, LM Bellan, ... Lubianca, Jaqueline Neves; Capp, Edison (org.). Promoção e proteção da saúde …, 2021 | 10 | 2021 |
| Vascular risk burden is a key player in the early progression of Alzheimer’s disease JP Ferrari-Souza, WS Brum, LA Hauschild, LU Da Ros, PCL Ferreira, ... Neurobiology of Aging 136, 88-98, 2024 | 9 | 2024 |
| Potential utility of plasma P-Tau and neurofilament light chain as surrogate biomarkers for preventive clinical trials PCL Ferreira, JP Ferrari-Souza, C Tissot, B Bellaver, DT Leffa, F Lussier, ... Neurology 101 (1), 38-45, 2023 | 9 | 2023 |
